eTheRNA is developing innovative immuno-oncology therapies based on its unique APC-activating messenger RNA platform.

Biotechnology

eTheRNA

Bernard Sagaert

Kris Thielemans

Lien Vangansewinkel

Philip van der Auwera

David Ricketts

Phil Challis

Stefaan De Koker

Marijn Dekkers

Kenneth Chien

John De Koning

Russell G. Greig

Kenneth Wils

This department focuses on advancing pharmacological research related to drug development and testing methodologies.

Pharmacology Research

The Research and Development team at eTheRNA focuses on advancing cutting-edge immuno-oncology therapies by integrating expertise in clinical and product development, pharmacology, and bioinformatics. They collaboratively design, test, and optimize messenger RNA formulations and analytical methods to ensure the efficacy and safety of innovative treatments aimed at activating antigen-presenting cells.

Research and Development

The Business Development team at eTheRNA focuses on identifying and nurturing strategic partnerships and collaborations to advance the company's innovative immuno-oncology therapies. They engage with potential partners, negotiate agreements, and manage alliance relationships, ensuring alignment with the company's growth objectives and facilitating the successful commercialization of its APC-activating mRNA platform.

Business Development

This department provides strategic direction and oversight for the organization.

Leadership Council

The Leadership Team at eTheRNA drives the strategic direction and vision of the company, overseeing the development of its innovative immuno-oncology therapies. Comprising key executives in corporate management, clinical and product development, business development, and discovery, the team ensures alignment across all functions, fosters collaboration, and accelerates the advancement of the APC-activating messenger RNA platform to bring transformative therapies to market.

Leadership Team

The Corporate Governance team at eTheRNA is responsible for ensuring the company's compliance with legal and regulatory requirements while promoting ethical standards and effective decision-making processes. This team, led by the Interim CEO and supported by the General Counsel and Board members, oversees corporate policies, risk management, and governance practices to align with the company’s mission in developing innovative immuno-oncology therapies.

eTheRNA

Org chart

Board & advisors

Teams

Pharmacology Research

Research and Development

Business Development

Leadership Council

Leadership Team

Corporate Governance

Offices

eTheRNA

Org chart

Board & advisors

Teams

Pharmacology Research

Research and Development

Business Development

Leadership Council

Leadership Team

Corporate Governance

Offices

Related companies